# Gal3‐CaN‐Smurf1 Complex Sequestrates FLCN‐FNIPs to Facilitate TFEB Activation in Response to Endomembrane Damage

**Authors:** Qin Xia, Ziwan Liu, Gaoqing Feng, Wanting Xu, HuaHua Wang, Haihang Su, Jiaqian Li, Dan Liu, Jun Qu, Tonghui Yu, Lei Dong

PMC · DOI: 10.1002/advs.202413241 · Advanced Science · 2025-09-17

## TL;DR

A complex involving Gal3, CaN, and Smurf1 helps activate TFEB during lysosomal damage by blocking its phosphorylation and promoting dephosphorylation.

## Contribution

The study reveals that the Gal3-CaN-Smurf1 complex sequesters FLCN-FNIPs to regulate TFEB activation in response to lysosomal damage.

## Key findings

- The Gal3-CaN-Smurf1 complex promotes TFEB dephosphorylation by sequestering FLCN-FNIPs.
- FLCNK462R and FNIP2K466R mutations reduce binding to the Gal3-CaN-Smurf1 complex.
- Smurf1 ubiquitinates TFEB, facilitating its activation in response to lysosomal damage.

## Abstract

Smurf1 mediates lysosomal biogenesis upon endomembrane damage by interacting with lysosomal injury sensor Gal3 and phosphatase CaN to form Gal3‐CaN‐Smurf1 complex, which is critical for TFEB dephosphorylation. However, whether Smurf1 plays a role in the inhibition of mTOR‐mediated TFEB phosphorylation is still unclear. TFEB phosphorylation by mTORC1 is strictly dependent on RagC/D GTPase activating protein FLCN. Here, we found that Smurf1 promotes the dissociation of RagC from TFEB upon lysosomal damage, selectively impairing TFEB phosphorylation. These findings suggest that the lysosomal damage‐induced Gal3‐CaN‐Smurf1 complex sequesters FLCN‐FNIPs to facilitate TFEB activation. This disruption of FLCN GAP function toward RagC/D impairs TFEB's lysosomal localization and phosphorylation. Notably, FLCNK462R and/or FNIP2K466R mutations reduce their binding affinity with the Gal3‐CaN‐Smurf1 complex, suggesting Smurf1‐mediated poly‐ubiquitylation of FLCNK462 and FNIP2K466 plays a role for pentamer formation. Indeed, sequestration of FLCN‐FNIPs stabilizes the Gal3‐CaN‐Smurf1 complex, wherein Smurf1 directly binds and ubiquitinates TFEB. This facilitates TFEB's dephosphorylation and activation. These findings indicate that Gal3‐CaN‐Smurf1 complex interconnects with the FLCN‐FNIPs to orchestrate TFEB localization and activity in response to lysosomal damage stress. Understanding Smurf1's regulation in the mTOR‐TFEB axis, which balances tumor growth and stress‐induced cell homeostasis, may provide novel therapeutic targets for tumor progression and drug resistance.

The schematic diagram illustrates the role of the recruitment of Gal3‐CaN‐Smurf1 complex in maintaining lysosomal membrane homeostasis upon damage. On the one hand, the Gal3‐CaN‐Smurf1 complex sequesters FLCN‐FNIPs to block the activation of RagC, where the active form RagC‐GDP is responsible for TFEB phosphorylation. On the other hand, FLCN‐FNIPs stabilizes Gal3‐CaN‐Smurf1 complex for the recruitment and CaN‐mediated dephosphorylation of TFEB.

## Linked entities

- **Genes:** LGALS3 (galectin 3) [NCBI Gene 3958], NUP214 (nucleoporin 214) [NCBI Gene 8021], SMURF1 (SMAD specific E3 ubiquitin protein ligase 1) [NCBI Gene 57154], FLCN (folliculin) [NCBI Gene 201163], RRAGC (Ras related GTP binding C) [NCBI Gene 64121], TFEB (transcription factor EB) [NCBI Gene 7942], FNIP2 (folliculin interacting protein 2) [NCBI Gene 57600]
- **Proteins:** LGALS3 (galectin 3), NUP214 (nucleoporin 214), SMURF1 (SMAD specific E3 ubiquitin protein ligase 1), FLCN (folliculin), RRAGC (Ras related GTP binding C), TFEB (transcription factor EB), FNIP2 (folliculin interacting protein 2)

## Full-text entities

- **Genes:** MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, FLCN (folliculin) [NCBI Gene 201163] {aka BHD, DENND8B, FLCL}, TFEB (transcription factor EB) [NCBI Gene 7942] {aka ALPHATFEB, BHLHE35, TCFEB}, LGALS3 (galectin 3) [NCBI Gene 3958] {aka CBP35, GAL3, GALBP, GALIG, L31, LGALS2}, SMURF1 (SMAD specific E3 ubiquitin protein ligase 1) [NCBI Gene 57154], RRAGC (Ras related GTP binding C) [NCBI Gene 64121] {aka GTR2, LNGODS, LNGOS, RAGC, TIB929}
- **Diseases:** tumor (MESH:D009369)
- **Mutations:** K466R

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12561182/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12561182/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12561182/full.md

---
Source: https://tomesphere.com/paper/PMC12561182